Global University Venturing

A roundup of all the latest news on www.globaluniversityventuring.com for our subscribers.

Lindsay Pearson, Adam Stoten and Liam Dolen have been appointed to Oxford University Innovation's board following the departures of Nicola Blackwood and Giles Kerr.

The Toronto oncological MRI agent spinout has been backed by Facit’s Prospects Oncology vehicle, to target applications including the identification and treatment of tumours in the brain.

Cambridge Enterprise joined Seedcamp and private investors for Sano Genetics’ seed round, proceeds of which will support the company’s data-sharing platform for genomic research.

Newly-founded MIT food pathogen sensor spinout Xibus has secured seed funding to develop its technology, which utilises synthetic particles to identify bacterial contamination.

Cambridge-founded chemicals products maker Aqdot has welcomed the return of IP Group and Parkwalk Advisors in its latest round, taking its funding total to $16.5m.

Novo and Sanofi Ventures returned to reinvest in Yale spinout Inozyme Pharma as it looks to advance its lead mineralisation disorder drug towards the clinic.

UTokyo's Innovation Platform joined subsidiaries of SBI, Sumitomo Mitsui and Mizuho Bank to help double genetic disorder treatment developer EdiGene's funding.

Cancer drug developer NH Theraguix was incubated by Satt Pulsalys to advance a nanoparticle-based drug for solid tumours that works by enhancing the efficacy of radiotherapy treatment and MRI scans.

Varian led a round for the targeted cancer drug developer that included existing investors such as Facit and Johnson & Johnson.

Sabic has equipped Mallinda with funding as the CU Boulder-founded thermoset resins provider gears up for the launch of its first commercial product.